ANGO
What one share of AngioDynamics holds
Surgical and Medical Instruments and Apparatus
AngioDynamics is a dynamic, diversified medical technology company committed to expanding treatment options and improving patient outcomes and quality of life by designing, manufacturing and selling products and technologies which aid clinicians in the treatment of patients with cardiovascular disease and cancer diagnoses.
AngioDynamics’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-08-31; the balance sheet is as of 2026-08-31.
| Sales | $7.80 |
|---|---|
| Profit | −$0.79 |
| Capex (buildings and equipment) | $0.05 |
| Free cash flow | $0.03 |
| Cash and investments | $0.80 |
| Book value | $3.86 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2017 | $7.37 | $0.14 | $0.08 | $1.44 | — | $13.98 |
| 2018 | $7.06 | $0.44 | $0.06 | $1.05 | — | $14.58 |
| 2019 | $7.22 | $1.64 | $0.08 | $0.92 | — | $16.35 |
| 2020 | $6.96 | −$4.39 | $0.19 | −$0.57 | — | $11.95 |
| 2021 | $7.59 | −$0.82 | $0.14 | $0.49 | — | $11.40 |
| 2022 | $8.11 | −$0.68 | $0.11 | −$0.29 | — | $10.84 |
| 2023 | $8.58 | −$1.33 | $0.10 | −$0.09 | — | $9.55 |
| 2024 | $7.56 | −$4.59 | $0.06 | −$0.76 | — | $5.08 |
| 2025 | $7.16 | −$0.83 | $0.11 | −$0.36 | — | $4.46 |
| 2026 | $7.71 | −$0.88 | $0.06 | $0.01 | — | $4.10 |